ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,155.72
-0.60%
Dow Jones
40,356.14
-0.76%
Gold vs US Dollar
2,398.34
-1.92%
Brent Oil
82.045
-2.42%
Bitcoin
66,928.60
4.63%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. CERo Therapeutics Holdings Inc (CERO) Share Price

CERO CERo Therapeutics Holdings Inc

0.2156
-0.0273 (-11.24%)
Last Updated: 20:00:19
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 CERo Therapeutics Holdings Inc NASDAQ:CERO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0273 -11.24 0.2156 0.214 0.2169 0.2278 0.2034 0.225 3,195,145 19:00:19   
 Type  Size  Price  Time  Units 
  500 0.2156 19:00:18 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CERO News
08/07/202413:00GLOBECERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024
13/06/202413:15GLOBECERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
06/06/202413:00GLOBECERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
15/05/202413:00GLOBECERo Therapeutics, Inc. Provides Corporate Update for Shareholders
30/04/202414:00GLOBECERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes
07/03/202412:00BWCERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients
Period
Draw mode
Data Downloads for CERO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest CERo Therapeutics Holdings Inc Articles